Cellular toxicities of gadolinium-based contrast agents used in magnetic resonance imaging

Contrast agents have been used in magnetic resonance imaging (MRI) as a radiological method. Gadolinium-based contrast agents (GBCAs), because of their paramagnetic characteristics, are the ones mostly used in MRI to increase signal intensity. However, the use of contrast media has raised concerns on cellular toxic risks of these agents. Studies showed the accumulation of gadolinium after injection to humans with or without renal impairment. Also, there are findings obtained under in vitro and/or in vivo conditions that revealed conflicting results for their cytotoxic and genotoxic effects. Some of them declared damage in cells and genetic material; some others did not. Abnormal cell growth and genetic aberration are critical because they may lead to carcinogenesis in somatic cells or may be transferred to the next generations through germ cells. Therefore, understanding the effect of GBCAs on cells is important for their safer usage in clinical administrations to generate high-quality contrast-enhanced magnetic resonance images. Because of all these reasons, cellular toxicities-mainly genotoxic and cytotoxic effects-of GBCAs were reviewed in this paper.

Automated summary

Contrast agents, specifically Gadolinium-based contrast agents (GBCAs), are commonly used in magnetic resonance imaging (MRI) to increase signal intensity. However, concerns have been raised regarding the cellular toxic risks of these agents. Accumulation of gadolinium after injection has been observed in humans, with or without renal impairment, and conflicting results have been obtained regarding the cytotoxic and genotoxic effects of GBCAs. Understanding the effects of GBCAs on cells is crucial for their safe usage in clinical applications.